A Practical Guide to Creating Effective Budget Impact Models GuideWhite Paper A Practical Guide to Creating Effective Budget Impact Models BaseCase empowers market access, medical, and sales teams to effectively engage decision-makers by translating complex…CertaraJuly 1, 2025
Everything you need to know about ILAP 2.0 White Paper Everything you need to know about ILAP 2.0 This white paper share’s key insights on the relaunch of MHRA’s Innovative Licensing and Access…CertaraMay 19, 2025
Rare Oncology Product Launch Playbook: Universal Strategies for Success in the U.S. and Europe White Paper Rare Oncology Product Launch Playbook: Universal Strategies for Success in the U.S. and Europe Lorem ipsum dolor sit amet consectetur. At venenatis urna sapien ut lorem enim. Morbi lectus…CertaraFebruary 28, 2025
The Benefits of Real-Time Nonclinical Safety Data Analysis White Paper The Benefits of Real-Time Nonclinical Safety Data Analysis Learn how SEND Explorer software helps nonclinical drug developers streamline performing real-time toxicology assessments of…CertaraJanuary 27, 2025
Clinical Metadata Standardization: Evaluating the Importance of a Metadata Repository in Clinical Trials White Paper Clinical Metadata Standardization: Evaluating the Importance of a Metadata Repository in Clinical Trials Whether you’re considering a metadata repository or want to learn about clinical metadata standardization, our…CertaraNovember 22, 2024
Streamline Regulatory Writing with AI-Powered Solutions White Paper Streamline Regulatory Writing with AI-Powered Solutions Learn how tailored AI solutions streamline regulatory writing, boosting efficiency, accuracy, & compliance.CertaraNovember 14, 2024
Assessing Transporter-Mediated DDIs White Paper Assessing Transporter-Mediated DDIs Discover strategies for evaluating transporter-mediated drug-drug interactions (DDIs) and their impact on drug safety, efficacy,…CertaraOctober 21, 2024
Clinical Trial Data Sharing Under EMA Policy 0070 White Paper Clinical Trial Data Sharing Under EMA Policy 0070 CertaraOctober 9, 2024
Evaluating the IRA’s Impact on Medicare Part B Biosimilar Reimbursement White Paper Evaluating the IRA’s Impact on Medicare Part B Biosimilar Reimbursement White paper exploring the IRA’s small but measurable impact in several key areasCertaraAugust 13, 2024
DSURs, RMPs, and PSURs – The Harmonization of Pharmacovigilance Documents White Paper DSURs, RMPs, and PSURs – The Harmonization of Pharmacovigilance Documents CertaraJuly 30, 2024